| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.11B | -3.6% |
| Cost of Revenue | $1.50B | -1.8% |
| Gross Profit | $618.0M | -7.5% |
| R&D Expense | $55.0M | +7.8% |
| SG&A Expense | $404.0M | +10.7% |
| Operating Income | -$26.0M | -115.1% |
| Interest Expense | $2.0M | -33.3% |
| Pre-tax Income | -$24.0M | -115.0% |
| Income Tax | -$223.0M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $300.0M | -28.1% |
| Accounts Receivable | $243.0M | -28.1% |
| Inventory | $545.0M | -12.9% |
| Current Assets | $1.20B | -20.7% |
| Total Assets | $5.64B | -5.0% |
| Current Liabilities | $490.0M | +7.5% |
| Long-term Debt | $1.35B | +2.7% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Capital Expenditures | $137.0M | -19.4% |
| Financing Cash Flow | -$479.0M | -29.1% |
| -2687.5% |
| Net Income | $169.0M | -5.1% |
| EPS (Basic) | $3.40 | +1.2% |
| EPS (Diluted) | $3.36 | +1.5% |
| Stockholders' Equity |
| $2.87B |
| -7.4% |